フォロー
Niels Hagenaars
Niels Hagenaars
所属不明
確認したメール アドレス: gupta.nl
タイトル
引用先
引用先
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against …
B Slütter, S Bal, C Keijzer, R Mallants, N Hagenaars, I Que, E Kaijzel, ...
Vaccine 28 (38), 6282-6291, 2010
2312010
Rational design of nasal vaccines
B Slütter, N Hagenaars, W Jiskoot
Journal of drug targeting 16 (1), 1-17, 2008
1592008
Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the …
N Hagenaars, E Mastrobattista, H Glansbeek, J Heldens, ...
Vaccine 26 (51), 6555-6563, 2008
872008
Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine
N Hagenaars, M Mania, P de Jong, I Que, R Nieuwland, B Slütter, ...
Journal of controlled release 144 (1), 17-24, 2010
712010
Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine
N Hagenaars, RJ Verheul, I Mooren, PH de Jong, E Mastrobattista, ...
Journal of controlled Release 140 (2), 126-133, 2009
682009
Physicochemical and immunological characterization of N, N, N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration
N Hagenaars, E Mastrobattista, RJ Verheul, I Mooren, HL Glansbeek, ...
Pharmaceutical research 26, 1353-1364, 2009
662009
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N, N, N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine
RJ Verheul, N Hagenaars, T van Es, EVB van Gaal, PH de Jong, S Bruijns, ...
European journal of pharmaceutical sciences 45 (4), 467-474, 2012
182012
Improving the evaluation of worldwide biomedical research output: classification method and standardised bibliometric indicators by disease
L van de Laar, T de Kruif, L Waltman, I Meijer, A Gupta, N Hagenaars
BMJ open 8 (6), e020818, 2018
62018
Towards an intranasal influenza vaccine based on whole inactivated influenza virus with N, N, N-trimethyl chitosan as adjuvant
N Hagenaars
Utrecht University, 2009
22009
The relationship between publication volume of biomedical research and burden of disease
N Hagenaars, T de Kruif, L van de Laar, L Waltman, I Meijer, M Levi, ...
OSF Preprints, 2019
12019
Quantifying the biomedical research agenda of the Netherlands
TM de Kruif, LA van de Laar, N Hagenaars
Nederlands Tijdschrift Voor Geneeskunde 161, D1333-D1333, 2017
2017
MATURATION OF HUMAN MONOCYTE DERIVED DENDRITIC CELLS BY TRIMETHYL CHITOSAN IS CORRELATED WITH ITS N-ACETYL GLUCOSAMINE (GLCNAC) CONTENT
RJ Verheul, N Hagenaars, T van Es, S Bruins, B Slütter, WE Hennink, ...
TAILORABLE TRIMETHYL CHITOSANS AS ADJUVANT FOR INTRANASAL IMMUNIZATION, 113, 2010
2010
Colloidal stability of N, N, N-trimethyl chitosan-whole inactivated influenza virus formulations
N Hagenaars, P de Jong, R Verheul, E Mastrobattista, W Jiskoot
Towards an intranasal influenza vaccine, 149, 2009
2009
Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines
N Hagenaars, E Mastrobattista, H Glansbeek, J Heldens, ...
Towards an intranasal influenza vaccine 26 (51), 53, 2009
2009
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of TMC
N Hagenaars, R Verheul, T van Es, E van Gaal, S Bruijns, P de Jong, ...
Towards an intranasal influenza vaccine, 133, 2009
2009
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–15